1st Annual European Congress on Hematology : Focus on Lymphoid Malignancies

1st Annual European Congress on Hematology : Focus on Lymphoid Malignancies is organized by Physicians Education Resource, LLC (PER) and would be held during Nov 04 - 05, 2016 at Hyatt Regency Paris Etoile, Paris, Ile-de-France, France.

The target audience for this medical event basically for healthcare professionals based outside of the United States. It is specifically designed for medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved in the treatment and management of patients with hematologic malignancies.

There has been tremendous progress in the treatment of lymphoid malignancies in recent years. Our ability to characterize these tumors has evolved considerably based on sophisticated molecular techniques, which are used to individualize risk stratification and management.

Objectives :

At the conclusion of this activity, you should be better prepared to :
• Describe current and evolving genomic and molecular biomarkers that can be used to stratify risk and inform clinical decision making in the management of hematologic malignancies
• Assess landmark clinical trial results in the context of how they impact evolving clinical practice paradigms and can be applied to personalize care and optimize outcomes
• Delineate effective strategies to proactively mitigate and manage predictable side effects related to the management of hematologic malignancies so as to maximize treatment outcomes
• Discuss effective strategies to assess and address nonadherence to oral oncolytic therapies in the treatment and management of hematological malignancies
• Evaluate recent clinical trial findings concerning novel compounds or strategies to manage hematologic malignancies
• Consider the therapeutic implications of emerging data on evolving treatment paradigms for patients with hematologic tumors